Walter Raasch
Institute of Experimental and Clinical Pharmacology and Toxicology
University of Lübeck
Ratzeburger Allee 160
23538 Lübeck
Germany
Name/email consistency: high
- Improved Insulin Sensitivity after Long-Term Treatment with AT1 Blockers Is Not Associated with PPARγ Target Gene Regulation. Müller-Fielitz, H., Landolt, J., Heidbreder, M., Werth, S., Vogt, F.M., Jöhren, O., Raasch, W. Endocrinology (2012)
- Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats. Raasch, W., Wittmershaus, C., Dendorfer, A., Voges, I., Pahlke, F., Dodt, C., Dominiak, P., Jöhren, O. Endocrinology (2006)
- Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR. Raasch, W., Jöhren, O., Schwartz, S., Gieselberg, A., Dominiak, P. J. Hypertens. (2004)
- Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation. Raasch, W., Dominiak, P., Ziegler, A., Dendorfer, A. Hypertension (2004)
- Norepinephrine release is reduced by I(1)-receptors in addition to alpha(2)-adrenoceptors. Raasch, W., Jungbluth, B., Schäfer, U., Häuser, W., Dominiak, P. Ann. N. Y. Acad. Sci. (2003)
- Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Raasch, W., Schäfer, U., Qadri, F., Dominiak, P. Br. J. Pharmacol. (2002)
- Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?. Raasch, W., Bartels, T., Schwartz, C., Häuser, W., Rütten, H., Dominiak, P. J. Hypertens. (2002)
- Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Raasch, W., Schäfer, U., Chun, J., Dominiak, P. Br. J. Pharmacol. (2001)
- Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats. Raasch, W., Betge, S., Dendorfer, A., Bartels, T., Dominiak, P. J. Hypertens. (2001)
- Modulation of MAO activity by imidazoline and guanidine derivatives. Raasch, W., Muhle, H., Dominiak, P. Ann. N. Y. Acad. Sci. (1999)